In today's blog, we introduce Dr Helena Glasová, MD PhD DevelopAKUre's new Medical Monitor from Bratislava, Slovakia. Dr Glasová will advise all three clinical sites in all medical matters relevant to the trial should they arise.
Where are you based and what is your regular job?
I work as an assistant professor and clinical pharmacologist (medical doctor) at the Institute of Pharmacology, Clinical and Experimental Pharmacology, Faculty of Medicine of the Slovak Medical University in Bratislava, Slovakia.
I teach Pharmacology (medical students in Slovak and English languages; other future health care professionals – nurses, midwives, paramedics, radiology technicians, physiotherapists), Clinical Pharmacology (Medical Specialty – post gradual studies for physicians), Methodology of Clinical Trials and Good Clinical Practice (national accredited certified method) and Medical Ethics and Bioethics.
I also work as a specialist at the outpatient clinic with the focus on Clinical Pharmacology and Hepatology (and the National Reference Centre for Treatment of Chronic Hepatitis). Here we see patients with a great variety of liver diseases. For a long time, I am interested in cholestatic and autoimmune liver diseases, such as Primary Biliary Cholangitis (also a rare disease), Non-Alcoholic Steatohepatitis and Drug-Induced Liver Disease.
I am also an external consultant for the Slovak Health Care Surveillance Authority, external evaluator for the Slovak State Institute for Drug Control. I am very fond of my collaboration with the various patient initiatives – the HepHelpClub (Slovak patients with liver diseases organisation), the European Liver Patients Association (ELPA) and the European Patients´ Academy on Therapeutic Innovation (EUPATI).
As a new medical monitor, I cooperate with the DevelopAKUre Consortium at the Biomedical Research Centre of the Slovak Academy of Sciences in Bratislava, Slovakia.
What attracted you to this position and what is a medical monitor?
Interestingly, I have been following alkaptonuria research for quite some time through a very good friend of mine - Dr Andrea Zaťková, PhD and the invitation to join the project came from her. Alkaptonuria research has a unique tradition in Slovakia; many outstanding Slovakian researchers were and are involved in it.
Medical monitor role is designed to assist the sites with study related questions, such as safety reporting issues, discussions regarding inclusion/exclusion concerns and deviations, safety trending analysis, and patient management questions.
Why do you want to be involved in Alkaptonuria research?
I would like to be part of the promising effort to bring a new pharmacological treatment option for patients with alkaptonuria.
What do you hope to achieve in this position?
I would like to support the team in order to achieve safe, accurate and successful study execution for the benefit of patients with alkaptonuria. I am very honoured and glad I can be part of this effort.
What are your hobbies/Interests?
Hiking (the Tatra Mountains), skiing, art (music - Avishai Cohen, books - Alexander McCall Smith), …
DevelopAKUre is a series of major international clinical trials, run by a consortium of 12 European partners. It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.
In today’s blog Chief investigator Prof. Ranganath reinforces the need for SONIA 2 pat.. ...more